These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6690740)

  • 21. In vitro culture and chemotherapy sensitivity testing of human transitional cell carcinoma.
    Lieber MM
    Urol Clin North Am; 1984 Nov; 11(4):725-33. PubMed ID: 6390916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the human tumor cloning assay for urologic malignancies with special emphasis on bladder cancer.
    Dittrich C; Schmidbauer CP; Havelec L; Lenzhofer R; Breyer S; Porpaczy P; Moser K
    Oncology; 1986; 43(1):40-5. PubMed ID: 3941801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonreciprocal chromosome translocation t(5;14) in cancers of the kidney: adenocarcinoma of the renal parenchyma and transitional cell carcinoma of the kidney pelvis.
    Hecht F; Berger CS; Sandberg AA
    Cancer Genet Cytogenet; 1985 Jan; 14(3-4):197-203. PubMed ID: 3967206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chromosomal analysis of primary superficial tumors of the bladder].
    Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
    J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unstable chromosome aberrations in bladder and renal cell carcinoma.
    Moriyama-Gonda N; Sumi H; Shiina H; Himeno Y; Ishibe T
    Cancer Genet Cytogenet; 1991 Oct; 56(1):65-72. PubMed ID: 1747870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
    Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
    Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic evidence of gene amplification in urothelial cancer--a possible mechanism of tumor invasiveness.
    Milasin J; Mićić S
    Urol Int; 1992; 48(3):258-60. PubMed ID: 1589912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premature chromosome condensation in carcinoma of the bladder: presumptive evidence for fusion of normal and malignant cells.
    Atkin NB
    Cytogenet Cell Genet; 1979; 23(3):217-9. PubMed ID: 436454
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cytogenetic analysis of transitional cell carcinoma of the bladder, stage B (pT2-3a/pN0)].
    Angulo JC; López JI; Sanchez-Chapado M
    Actas Urol Esp; 1994 Jun; 18(6):651-5. PubMed ID: 7942216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding.
    Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
    Br J Cancer; 1999 Sep; 81(1):6-12. PubMed ID: 10487605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
    Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
    Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
    Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
    Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate-risk urothelial carcinoma: an unresolved problem?
    Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
    Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
    Yu DS; Chen HI; Chang SY
    Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
    Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
    Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.
    Falor WH; Ward RM
    Acta Cytol; 1976; 20(3):272-5. PubMed ID: 1064279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of bladder cancer: a cytogeneticist's perspective.
    Wolff DJ
    Cytogenet Genome Res; 2007; 118(2-4):177-81. PubMed ID: 18000368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.